Veracyte Inc (VCYT)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $1.96B
Last updated: Nov 17, 2026 at 11:05 AM ET
Veracyte Inc (VCYT) Competitors
The companies most similar to Veracyte are NeoGenomics (NEO), Personalis (PSNL) and CareDx (CDNA). Veracyte trades at 13.3x earnings, against a median of 48.2x for the 5 of these companies with a P/E. By market cap, Veracyte ranks 8th of the 13 companies on this page; Revvity (RVTY) is the largest at $17.24B.
Peer Comparison
VCYT's ROIC of 8.2% is above the peer median of -3.9%, and its revenue growth of 15.1% is above the median of 9.4%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Veracyte (VCYT) | $1.96B | 13.3x | 3.3x | 21.8% | 8.2% | 15.1% | 0.00% |
| NeoGenomics Inc (NEO) | $2.07B | 228.9x | 2.6x | -4.1% | -2.5% | 11.4% | 0.00% |
| Personalis Inc (PSNL) | $1.70B | N/A | 20.9x | -147.7% | N/A | 76.6% | 0.00% |
| CareDx Inc (CDNA) | $4.09B | 48.2x | 6.4x | 25.9% | N/A | 39.3% | 0.00% |
| Fulgent Genetics Inc (FLGT) | $688.98M | N/A | 2.0x | -27.5% | -12.1% | 7.5% | 0.00% |
| Castle Biosciences Inc (CSTL) | $1.04B | N/A | 2.7x | -6.1% | -5.4% | 23.9% | 0.00% |
| Opko Health Inc (OPK) | $1.25B | N/A | 2.4x | -22.6% | -6.2% | 15.9% | 0.00% |
| Adaptive Biotechnologies Corp (ADPT) | $4.70B | N/A | 15.0x | -23.7% | N/A | -10.7% | 0.00% |
| Myriad Genetics Inc (MYGN) | $542.92M | N/A | 0.7x | -16.1% | -29.5% | -1.5% | 0.00% |
| GRAIL, LLC (GRAL) | $5.21B | N/A | 29.6x | -243.8% | N/A | 3.7% | 0.00% |
| Sotera Health Co (SHC) | $4.74B | 17.1x | 3.8x | 14.1% | 9.0% | 4.4% | 0.00% |
| Revvity Inc. (RVTY) | $17.24B | 26.8x | 5.6x | 8.6% | 3.4% | 4.3% | 0.19% |
| RadNet Inc (RDNT) | $6.02B | 141.5x | 2.5x | -0.9% | 2.7% | 22.1% | 0.00% |
| Peer median | $3.08B | 48.2x | 3.3x | -11.1% | -3.9% | 9.4% | 0.00% |
Similar Companies
These are the 12 companies most similar to Veracyte, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Diagnostics & Research.
| Company | About | Peers |
|---|---|---|
| NeoGenomics Inc (NEO) | NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. | NEO competitors |
| Personalis Inc (PSNL) | Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California. | PSNL competitors |
| CareDx Inc (CDNA) | CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. | CDNA competitors |
| Fulgent Genetics Inc (FLGT) | Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. | FLGT competitors |
| Castle Biosciences Inc (CSTL) | Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests... | CSTL competitors |
| Opko Health Inc (OPK) | OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico... | OPK competitors |
| Adaptive Biotechnologies Corp (ADPT) | Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. | ADPT competitors |
| Myriad Genetics Inc (MYGN) | Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized... | MYGN competitors |
| GRAIL, LLC (GRAL) | GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics... | GRAL competitors |
| Sotera Health Co (SHC) | Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical... | SHC competitors |
| Revvity Inc. (RVTY) | Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. | RVTY competitors |
| RadNet Inc (RDNT) | RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California. | RDNT competitors |
Frequently Asked Questions About VCYT
Who are Veracyte's main competitors?
The companies most similar to Veracyte include NeoGenomics (NEO), Personalis (PSNL), CareDx (CDNA), Fulgent Genetics (FLGT) and Castle Biosciences (CSTL), listed from the closest match.
Who is Veracyte's biggest competitor?
Revvity (RVTY) is the largest of the similar companies at $17.24B; NeoGenomics (NEO) is the closest match by business profile, size, sector and industry.
How does VCYT stock compare with its competitors?
VCYT's P/E is 13.3x against a peer median of 48.2x; its P/S is 3.3x against a peer median of 3.3x; its net margin is 21.8% against a peer median of -11.1%.
Which of Veracyte's competitors pays a higher dividend?
Veracyte pays no dividend. Revvity (RVTY) has a higher forward dividend yield; Revvity (RVTY) has the highest at 0.19%.
Is Veracyte bigger than its competitors?
No. Veracyte is 8th by market cap among the 13 companies on this page; the largest is Revvity (RVTY) at $17.24B.
VCYT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts